BerGenBio ASA (OSL:BGBIO)
Norway · Delayed Price · Currency is NOK 1.160
-0.018 (-1.53%)
Sep 8, 2025, 4:06 PM CET
BerGenBio ASA Market Cap
BerGenBio ASA has a market cap or net worth of 45.34 million as of September 8, 2025. Its market cap has decreased by -89.53% in one year.
Market Cap
45.34M
Enterprise Value
-24.17M
Revenue
5.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.16
Market Cap Chart
Since April 7, 2017, BerGenBio ASA's market cap has decreased from 1.24B to 45.34M, a decrease of -96.35%. That is a compound annual growth rate of -32.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 45.34M | -85.82% |
| Dec 30, 2024 | 319.77M | -57.22% |
| Dec 29, 2023 | 747.46M | 12.86% |
| Dec 30, 2022 | 662.29M | -63.08% |
| Dec 30, 2021 | 1.79B | -36.16% |
| Dec 30, 2020 | 2.81B | 88.93% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.73B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 1.64B |
| ArcticZymes Technologies ASA | 1.39B |
| Thor Medical ASA | 1.27B |
| Vistin Pharma ASA | 1.03B |
| Omda AS | 1.00B |
| Gentian Diagnostics ASA | 863.65M |